Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS-6: Fondaparinux in STEMI
NCT00064428Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2003
- Primary completion
- Feb 2006
- Modality
- Allosteric Modulators
01
Overview
A Phase 3 trial of fondaparinux in ST elevation myocardial infarction (STEMI), sponsored by GSK. Started Aug 2003; status: completed.
02
Drugs
fondaparinux
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00064428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064428.